NASDAQ · Biotechnology

ETON (ETON) Stock

$45.49 +7.53% NASDAQ: ETON Healthcare

Valuation

MetricValue
Price$45.49
Market Cap$1.25B
P/E Ratio-178.00
P/B Ratio31.88
P/S Ratio10.24
EPS (TTM)$-0.17
52-Week High$45.49
52-Week Low$13.09
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-19.23%
ROA-5.43%
ROCE0.00%
Gross Margin0.00%
Operating Margin2.35%
Net Margin-1.70%
Debt/Equity0.40
Current Ratio1.61

Annual Financials (USD)

Metric20212022202320242025
Revenue$22.0M$21.0M$32.0M$39.0M$80.0M
Operating Profit$-1.0M$-8.0M$-1.0M$-3.0M$0
Net Profit$-2.0M$-9.0M$-1.0M$-4.0M$-5.0M
EPS$-0.08$-0.36$-0.04$-0.15$-0.17
Op Margin-6.8%-38.9%-3.8%-6.7%0.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$27.0M$25.0M$32.0M$76.0M$92.0M
Total Liabilities$10.0M$12.0M$16.0M$52.0M$66.0M
Cash$14.0M$16.0M$21.0M$15.0M$26.0M
Borrowings$7.0M$7.0M$5.0M$30.0M$31.0M

Latest News

Eton Pharmaceuticals (ETON) Moves 13.8% Higher: Will This Strength Last? Zacks · Jul 20, 2026 Apple upgraded, Brinker initiated: Wall Street's top analyst calls The Fly · Jul 17, 2026 Canaccord Genuity Initiates Eton Pharmaceuticals at Buy With $60 Price Target MT Newswires · Jul 17, 2026 Eton Pharmaceuticals Insider Sold Shares Worth $1,623,795, According to a Recent SEC Filing MT Newswires · Jun 17, 2026 Eton Pharmaceuticals Insider Sold Shares Worth $3,229,923, According to a Recent SEC Filing MT Newswires · May 28, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-5.0M$5.0M$7.0M$1.0M$11.0M
Investing Cash Flow$-6.0M$-6.0M$-2.0M$-40.0M$-1.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$-7.0M$2.0M$5.0M$-6.0M$11.0M
Free Cash Flow$-8.0M$2.0M$6.0M$1.0M$10.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield1.73%
Quick Ratio0.88
Interest Coverage0.00
Return 1Y188.69%
Return 3Y1406.48%
Return 5Y584.49%

Ownership

Insiders Held5.32%
Institutions Held65.63%
Institutions Float Held69.32%
Institutional HolderSharesReport Date
Opaleye Management Inc.2,860,0002026-03-31
EcoR1 Capital, LLC2,171,9382026-03-31
Blackrock Inc.1,717,2862026-03-31
Nantahala Capital Management, LLC1,175,9512026-03-31
Vanguard Capital Management LLC994,0892026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADCTADC Therapeutics S.A. $1.19 +3.48% -1.09 $151.36M 0.00%
BCYCBicycle Therapeutics plc $4.22 +0.24% -1.34 $292.84M 0.00%
FULC $3.73 +0.13% -5.17 $201.56M 0.00%
LCTX $1.13 -0.88% -17.61 $281.71M 0.00%
LXRX $2.47 +4.66% -15.93 $1.10B 0.00%

About ETON

ETON is led by CEO Sean E. Brynjelsen, employs 31 people, headquartered in US, publicly traded since 2018.

ETON stock trades at $45.49 with a market capitalization of $1.25B. The stock is valued at a price-to-earnings (P/E) ratio of -178.00, price-to-book of 31.88, price-to-sales of 10.24. Over the past 52 weeks the stock has ranged between $13.09 and $45.49, and currently trades at its 52-week high.

On profitability, ETON generates a return on equity (ROE) of -19.23%, return on capital employed of 0.00%, an operating margin of 2.35%, a net profit margin of -1.70%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides